TTK peptides and vaccines including the same

Details for Australian Patent Application No. 2010248702 (hide)

Owner Oncotherapy Science, Inc.

Inventors Nakamura, Yusuke; Tsunoda, Takuya; Ohsawa, Ryuji; Yoshimura, Sachiko; Watanabe, Tomohisa

Agent Davies Collison Cave

Pub. Number AU-A-2010248702

PCT Pub. Number WO2010/131452

Priority 61/216,017 11.05.09 US

Filing date 10 May 2010

Wipo publication date 18 November 2010

International Classifications

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/131452 Priority application(s): WO2010/131452

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010248710-Anti-tumor agent comprising tegafurgimeracil-oteracil potassium combination drug and oxaliplatin

2010248688-Playback method for optical disc, playback apparatus for optical disc, nontransitory computer program product